Literature DB >> 31771763

Too much of a good thing: Detrimental effects of interferon.

Nancy C Reich1.   

Abstract

Healthy tissues of the body express relatively low basal levels of interferons. However, following detection of microbial invasion by sentinel receptors, a cascade of events initiates leading to the transcriptional induction of interferon genes. Interferons are secreted and act primarily as paracrine cytokines to bind neighboring cell surface receptors. Binding to interferon receptors activates a signal pathway to the nucleus inducing a set of interferon-stimulated genes. The biological activity of these genes confers the unique antiviral and innate immune response of interferons. The rapid induction of interferons is critical to survival, and equally critical is the recovery from this defensive state. Either an aberrant response to infection or an inherited genetic disorder that leads to sustained or increased interferon levels can tip the balance towards pathogenesis.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Autoinflammatory disease; Inborn genetic mutations; Type I interferonopathy

Mesh:

Substances:

Year:  2019        PMID: 31771763      PMCID: PMC6884074          DOI: 10.1016/j.smim.2019.101282

Source DB:  PubMed          Journal:  Semin Immunol        ISSN: 1044-5323            Impact factor:   11.130


  94 in total

1.  The adaptor protein MITA links virus-sensing receptors to IRF3 transcription factor activation.

Authors:  Bo Zhong; Yan Yang; Shu Li; Yan-Yi Wang; Ying Li; Feici Diao; Caoqi Lei; Xiao He; Lu Zhang; Po Tien; Hong-Bing Shu
Journal:  Immunity       Date:  2008-09-25       Impact factor: 31.745

Review 2.  Regulation of effector and memory T-cell functions by type I interferon.

Authors:  Jonathan P Huber; J David Farrar
Journal:  Immunology       Date:  2011-02-14       Impact factor: 7.397

3.  Transcriptional regulation of interferon-stimulated genes: a DNA response element and induced proteins that recognize it.

Authors:  D Levy; N Reich; D Kessler; R Pine; J E Darnell
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1988

4.  Identification of a pathogenic variant in TREX1 in early-onset cerebral systemic lupus erythematosus by Whole-exome sequencing.

Authors:  Julia I Ellyard; Rebekka Jerjen; Jaime L Martin; Adrian Y S Lee; Matthew A Field; Simon H Jiang; Jean Cappello; Svenja K Naumann; T Daniel Andrews; Hamish S Scott; Marco G Casarotto; Christopher C Goodnow; Jeffrey Chaitow; Virginia Pascual; Paul Hertzog; Stephen I Alexander; Matthew C Cook; Carola G Vinuesa
Journal:  Arthritis Rheumatol       Date:  2014-12       Impact factor: 10.995

5.  A human 15-kDa IFN-induced protein induces the secretion of IFN-gamma.

Authors:  M Recht; E C Borden; E Knight
Journal:  J Immunol       Date:  1991-10-15       Impact factor: 5.422

6.  The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses.

Authors:  David L Boone; Emre E Turer; Eric G Lee; Regina-Celeste Ahmad; Matthew T Wheeler; Colleen Tsui; Paula Hurley; Marcia Chien; Sophia Chai; Osamu Hitotsumatsu; Elizabeth McNally; Cecile Pickart; Averil Ma
Journal:  Nat Immunol       Date:  2004-08-29       Impact factor: 25.606

7.  Familial chilblain lupus due to a gain-of-function mutation in STING.

Authors:  Nadja König; Christoph Fiehn; Christine Wolf; Max Schuster; Emanuel Cura Costa; Victoria Tüngler; Hugo Ariel Alvarez; Osvaldo Chara; Kerstin Engel; Raphaela Goldbach-Mansky; Claudia Günther; Min Ae Lee-Kirsch
Journal:  Ann Rheum Dis       Date:  2016-08-26       Impact factor: 19.103

8.  Identification of a nuclear Stat1 protein tyrosine phosphatase.

Authors:  Johanna ten Hoeve; Maria de Jesus Ibarra-Sanchez; Yubin Fu; Wei Zhu; Michel Tremblay; Michael David; Ke Shuai
Journal:  Mol Cell Biol       Date:  2002-08       Impact factor: 4.272

9.  ERIS, an endoplasmic reticulum IFN stimulator, activates innate immune signaling through dimerization.

Authors:  Wenxiang Sun; Yang Li; Lu Chen; Huihui Chen; Fuping You; Xiang Zhou; Yi Zhou; Zhonghe Zhai; Danying Chen; Zhengfan Jiang
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-11       Impact factor: 11.205

10.  A mutation in TREX1 that impairs susceptibility to granzyme A-mediated cell death underlies familial chilblain lupus.

Authors:  Min Ae Lee-Kirsch; Dipanjan Chowdhury; Scott Harvey; Maoliang Gong; Lydia Senenko; Kerstin Engel; Christiane Pfeiffer; Thomas Hollis; Manfred Gahr; Fred W Perrino; Judy Lieberman; Norbert Hubner
Journal:  J Mol Med (Berl)       Date:  2007-04-18       Impact factor: 5.606

View more
  5 in total

1.  IRF3 inhibits nuclear translocation of NF-κB to prevent viral inflammation.

Authors:  Sonam Popli; Sukanya Chakravarty; Shumin Fan; Anna Glanz; Siddhesh Aras; Laura E Nagy; Ganes C Sen; Ritu Chakravarti; Saurabh Chattopadhyay
Journal:  Proc Natl Acad Sci U S A       Date:  2022-09-06       Impact factor: 12.779

Review 2.  Human guanylate binding proteins: nanomachines orchestrating host defense.

Authors:  Miriam Kutsch; Jörn Coers
Journal:  FEBS J       Date:  2021-01-12       Impact factor: 5.622

Review 3.  Crosstalk between Interleukin-1β and Type I Interferons Signaling in Autoinflammatory Diseases.

Authors:  Philippe Georgel
Journal:  Cells       Date:  2021-05-08       Impact factor: 6.600

4.  Treatment with Commonly Used Antiretroviral Drugs Induces a Type I/III Interferon Signature in the Gut in the Absence of HIV Infection.

Authors:  Sean M Hughes; Claire N Levy; Fernanda L Calienes; Joanne D Stekler; Urvashi Pandey; Lucia Vojtech; Alicia R Berard; Kenzie Birse; Laura Noël-Romas; Brian Richardson; Jackelyn B Golden; Michael Cartwright; Ann C Collier; Claire E Stevens; Marcel E Curlin; Timothy H Holtz; Nelly Mugo; Elizabeth Irungu; Elly Katabira; Timothy Muwonge; Javier R Lama; Jared M Baeten; Adam Burgener; Jairam R Lingappa; M Juliana McElrath; Romel Mackelprang; Ian McGowan; Ross D Cranston; Mark J Cameron; Florian Hladik
Journal:  Cell Rep Med       Date:  2020-09-22

Review 5.  Innate Immune Responses to Acute Viral Infection During Pregnancy.

Authors:  Emily F Cornish; Iva Filipovic; Fredrika Åsenius; David J Williams; Thomas McDonnell
Journal:  Front Immunol       Date:  2020-09-30       Impact factor: 8.786

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.